BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: O'Leary OF, Dinan TG, Cryan JF. Faster, better, stronger: towards new antidepressant therapeutic strategies. Eur J Pharmacol 2015;753:32-50. [PMID: 25092200 DOI: 10.1016/j.ejphar.2014.07.046] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 7.1] [Reference Citation Analysis]
Number Citing Articles
1 Codagnone MG, Kara N, Ratsika A, Levone BR, van de Wouw M, Tan LA, Cunningham JI, Sanchez C, Cryan JF, O’leary OF. Inhibition of FKBP51 induces stress resilience and alters hippocampal neurogenesis. Mol Psychiatry. [DOI: 10.1038/s41380-022-01755-9] [Reference Citation Analysis]
2 Yuan J, Yao JQ, Fang XX, Dai W, Wang YH, Zhang LM, Li YF. Involvement of regulation of the excitation:inhibition functional balance in the mPFC in the antidepressant-anxiolytic effect of YL-IPA08, a novel TSPO ligand. Metab Brain Dis 2022. [PMID: 35779149 DOI: 10.1007/s11011-022-00961-2] [Reference Citation Analysis]
3 Dames S, Kryskow P, Watler C. A Cohort-Based Case Report: The Impact of Ketamine-Assisted Therapy Embedded in a Community of Practice Framework for Healthcare Providers With PTSD and Depression. Front Psychiatry 2021;12:803279. [PMID: 35095617 DOI: 10.3389/fpsyt.2021.803279] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Chen X, Yang T, Zhang C, Ma Z. RNA-seq based transcriptome analysis of ethanol extract of saffron protective effect against corticosterone-induced PC12 cell injury. BMC Complement Med Ther 2022;22:29. [PMID: 35101009 DOI: 10.1186/s12906-022-03516-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Silva S, Bicker J, Falcão A, Fortuna A. Antidepressants and Circadian Rhythm: Exploring Their Bidirectional Interaction for the Treatment of Depression. Pharmaceutics 2021;13:1975. [PMID: 34834391 DOI: 10.3390/pharmaceutics13111975] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Wang SM, Kim NY, Na HR, Lim HK, Woo YS, Pae CU, Bahk WM. Rapid Onset of Intranasal Esketamine in Patients with Treatment Resistant Depression and Major Depression with Suicide Ideation: A Meta-Analysis. Clin Psychopharmacol Neurosci 2021;19:341-54. [PMID: 33888663 DOI: 10.9758/cpn.2021.19.2.341] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
7 Yan T, Qiu Y, Yu X, Yang L. Glymphatic Dysfunction: A Bridge Between Sleep Disturbance and Mood Disorders. Front Psychiatry 2021;12:658340. [PMID: 34025481 DOI: 10.3389/fpsyt.2021.658340] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
8 Sotoyama H, Namba H, Kobayashi Y, Hasegawa T, Watanabe D, Nakatsukasa E, Sakimura K, Furuyashiki T, Nawa H. Resting-state dopaminergic cell firing in the ventral tegmental area negatively regulates affiliative social interactions in a developmental animal model of schizophrenia. Transl Psychiatry 2021;11:236. [PMID: 33888687 DOI: 10.1038/s41398-021-01346-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
9 Johnson CR, Kangas BD, Jutkiewicz EM, Winger G, Bergman J, Coop A, Woods JH. Novel Antimuscarinic Antidepressant-like Compounds with Reduced Effects on Cognition. J Pharmacol Exp Ther 2021;377:336-45. [PMID: 33712507 DOI: 10.1124/jpet.120.000337] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Xu J, Tao J, Wang J. Design and Application in Delivery System of Intranasal Antidepressants. Front Bioeng Biotechnol 2020;8:626882. [PMID: 33409272 DOI: 10.3389/fbioe.2020.626882] [Cited by in Crossref: 4] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
11 El Yacoubi M, Vaugeois JM, Jamain S. Antidepressant-like effect of low dose of scopolamine in the H/Rouen genetic mouse model of depression. Fundam Clin Pharmacol 2021;35:645-9. [PMID: 33314271 DOI: 10.1111/fcp.12639] [Reference Citation Analysis]
12 Zorkina Y, Abramova O, Ushakova V, Morozova A, Zubkov E, Valikhov M, Melnikov P, Majouga A, Chekhonin V. Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations. Molecules 2020;25:E5294. [PMID: 33202839 DOI: 10.3390/molecules25225294] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
13 K V A, Mohan AS, Chakravarty S. Rapid acting antidepressants in the mTOR pathway: Current evidence. Brain Research Bulletin 2020;163:170-7. [DOI: 10.1016/j.brainresbull.2020.07.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Yang L, Zhou Y, Jia H, Qi Y, Tu S, Shao A. Affective Immunology: The Crosstalk Between Microglia and Astrocytes Plays Key Role? Front Immunol 2020;11:1818. [PMID: 32973758 DOI: 10.3389/fimmu.2020.01818] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
15 Araj-Khodaei M, Noorbala AA, Yarani R, Emadi F, Emaratkar E, Faghihzadeh S, Parsian Z, Alijaniha F, Kamalinejad M, Naseri M. A double-blind, randomized pilot study for comparison of Melissa officinalis L. and Lavandula angustifolia Mill. with Fluoxetine for the treatment of depression. BMC Complement Med Ther 2020;20:207. [PMID: 32620104 DOI: 10.1186/s12906-020-03003-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
16 Vitorino C, Silva S, Gouveia F, Bicker J, Falcão A, Fortuna A. QbD-driven development of intranasal lipid nanoparticles for depression treatment. Eur J Pharm Biopharm 2020;153:106-20. [PMID: 32525033 DOI: 10.1016/j.ejpb.2020.04.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
17 Li Y. A hypothesis of monoamine (5-HT) – Glutamate/GABA long neural circuit: Aiming for fast-onset antidepressant discovery. Pharmacology & Therapeutics 2020;208:107494. [DOI: 10.1016/j.pharmthera.2020.107494] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
18 Zhang Y, Zheng G, Fu T, Hong J, Li F, Yao X, Xue W, Zhu F. The binding mode of vilazodone in the human serotonin transporter elucidated by ligand docking and molecular dynamics simulations. Phys Chem Chem Phys 2020;22:5132-44. [PMID: 32073004 DOI: 10.1039/c9cp05764a] [Cited by in Crossref: 4] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
19 Gruenbaum BF, Kutz R, Zlotnik A, Boyko M. Blood glutamate scavenging as a novel glutamate-based therapeutic approach for post-stroke depression. Ther Adv Psychopharmacol 2020;10:2045125320903951. [PMID: 32110376 DOI: 10.1177/2045125320903951] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
20 McCue M, Parikh SV, Mucha L, Sarkey S, Cao C, Eramo A, Opler M, Webber-Lind B, François C. Adapting the Goal Attainment Approach for Major Depressive Disorder. Neurol Ther 2019;8:167-76. [PMID: 31435869 DOI: 10.1007/s40120-019-00151-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Camargo A, Pazini FL, Rosa JM, Wolin IA, Moretti M, Rosa PB, Neis VB, Rodrigues ALS. Augmentation effect of ketamine by guanosine in the novelty-suppressed feeding test is dependent on mTOR signaling pathway. Journal of Psychiatric Research 2019;115:103-12. [DOI: 10.1016/j.jpsychires.2019.05.017] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
22 Potměšil P. What combinations of agomelatine with other antidepressants could be successful during the treatment of major depressive disorder or anxiety disorders in clinical practice? Ther Adv Psychopharmacol 2019;9:2045125319855206. [PMID: 31312426 DOI: 10.1177/2045125319855206] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
23 Vitorino C, Silva S, Bicker J, Falcão A, Fortuna A. Antidepressants and nose-to-brain delivery: drivers, restraints, opportunities and challenges. Drug Discov Today 2019;24:1911-23. [PMID: 31181188 DOI: 10.1016/j.drudis.2019.06.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
24 Lopes IS, Oliveira ICM, Capibaribe VCC, Valentim JT, da Silva DMA, de Souza AG, de Araújo MA, Chaves RDC, Gutierrez SJC, Barbosa Filho JM, Macêdo DS, de Sousa FCF. Riparin II ameliorates corticosterone-induced depressive-like behavior in mice: Role of antioxidant and neurotrophic mechanisms. Neurochemistry International 2018;120:33-42. [DOI: 10.1016/j.neuint.2018.07.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
25 Bhattacharya A, Jones DNC. Emerging role of the P2X7-NLRP3-IL1β pathway in mood disorders. Psychoneuroendocrinology 2018;98:95-100. [PMID: 30121550 DOI: 10.1016/j.psyneuen.2018.08.015] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 8.0] [Reference Citation Analysis]
26 Nuno-Perez A, Tchenio A, Mameli M, Lecca S. Lateral Habenula Gone Awry in Depression: Bridging Cellular Adaptations With Therapeutics. Front Neurosci 2018;12:485. [PMID: 30083090 DOI: 10.3389/fnins.2018.00485] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
27 Wang SM, Han C, Lee SJ, Patkar AA, Masand PS, Pae CU. Five potential therapeutic agents as antidepressants: a brief review and future directions. Expert Rev Neurother 2015;15:1015-29. [PMID: 26312645 DOI: 10.1586/14737175.2015.1071192] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
28 Huang Z, Huang X, Wang Q, Jiang R, Sun G, Xu Y, Wu Q. Extract of Euryale ferox Salisb exerts antidepressant effects and regulates autophagy through the adenosine monophosphate-activated protein kinase-UNC-51-like kinase 1 pathway: ES-PE ACTIVATED AUTOPHAGY BY REGULATING THE AMPK PATHWAY. IUBMB Life 2018;70:300-9. [DOI: 10.1002/iub.1731] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
29 Khan H, Amin S, Patel S. Targeting BDNF modulation by plant glycosides as a novel therapeutic strategy in the treatment of depression. Life Sciences 2018;196:18-27. [DOI: 10.1016/j.lfs.2018.01.013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
30 Prado CE, Watt S, Crowe SF. A meta-analysis of the effects of antidepressants on cognitive functioning in depressed and non-depressed samples. Neuropsychol Rev 2018;28:32-72. [DOI: 10.1007/s11065-018-9369-5] [Cited by in Crossref: 57] [Cited by in F6Publishing: 64] [Article Influence: 14.3] [Reference Citation Analysis]
31 Allen AP, Naughton M, Dowling J, Walsh A, O'Shea R, Shorten G, Scott L, McLoughlin DM, Cryan JF, Clarke G, Dinan TG. Kynurenine pathway metabolism and the neurobiology of treatment-resistant depression: Comparison of multiple ketamine infusions and electroconvulsive therapy. J Psychiatr Res 2018;100:24-32. [PMID: 29475018 DOI: 10.1016/j.jpsychires.2018.02.011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
32 Li Y, Li L, Hölscher C. Therapeutic Potential of Genipin in Central Neurodegenerative Diseases. CNS Drugs 2016;30:889-97. [PMID: 27395402 DOI: 10.1007/s40263-016-0369-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
33 Ding XF, Li YH, Chen JX, Sun LJ, Jiao HY, Wang XX, Zhou Y. Involvement of the glutamate/glutamine cycle and glutamate transporter GLT-1 in antidepressant-like effects of Xiao Yao san on chronically stressed mice. BMC Complement Altern Med 2017;17:326. [PMID: 28629384 DOI: 10.1186/s12906-017-1830-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 5.4] [Reference Citation Analysis]
34 Cussotto S, Cryan JF, O'Leary OF. The hippocampus and dorsal raphe nucleus are key brain areas associated with the antidepressant effects of lithium augmentation of desipramine. Neurosci Lett 2017;648:14-20. [PMID: 28351776 DOI: 10.1016/j.neulet.2017.03.040] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
35 Scott KA, de Kloet AD, Smeltzer MD, Krause EG, Flak JN, Melhorn SJ, Foster MT, Tamashiro KLK, Sakai RR. Susceptibility or resilience? Prenatal stress predisposes male rats to social subordination, but facilitates adaptation to subordinate status. Physiol Behav 2017;178:117-25. [PMID: 28284881 DOI: 10.1016/j.physbeh.2017.03.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
36 Papadimitropoulou K, Vossen C, Karabis A, Donatti C, Kubitz N. Comparative efficacy and tolerability of pharmacological and somatic interventions in adult patients with treatment-resistant depression: a systematic review and network meta-analysis. Curr Med Res Opin 2017;33:701-11. [PMID: 28035869 DOI: 10.1080/03007995.2016.1277201] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 8.2] [Reference Citation Analysis]
37 Strasburger SE, Bhimani PM, Kaabe JH, Krysiak JT, Nanchanatt DL, Nguyen TN, Pough KA, Prince TA, Ramsey NS, Savsani KH, Scandlen L, Cavaretta MJ, Raffa RB. What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities. J Clin Pharm Ther 2017;42:147-54. [PMID: 28111761 DOI: 10.1111/jcpt.12497] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 7.6] [Reference Citation Analysis]
38 Pessoa-Mahana H, Silva-Matus P, Pessoa-Mahana CD, Chung H, Iturriaga-Vásquez P, Quiroz G, Möller-Acuña P, Zapata-Torres G, Saitz-Barría C, Araya-Maturana R, Reyes-Parada M. Synthesis and Docking of Novel 3-Indolylpropyl Derivatives as New Polypharmacological Agents Displaying Affinity for 5-HT1A R/SERT. Arch Pharm (Weinheim) 2017;350. [PMID: 27981607 DOI: 10.1002/ardp.201600271] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
39 Rychlik M, Bollen E, Rygula R. Ketamine decreases sensitivity of male rats to misleading negative feedback in a probabilistic reversal-learning task. Psychopharmacology (Berl) 2017;234:613-20. [PMID: 27933365 DOI: 10.1007/s00213-016-4497-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
40 Podkowa K, Podkowa A, Sałat K, Lenda T, Pilc A, Pałucha-Poniewiera A. Antidepressant-like effects of scopolamine in mice are enhanced by the group II mGlu receptor antagonist LY341495. Neuropharmacology 2016;111:169-79. [PMID: 27569995 DOI: 10.1016/j.neuropharm.2016.08.031] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
41 Cui J, Yang K, Yu X, Wang JL, Li J, Zhang Y, Li H. Chronic Fluoxetine Treatment Upregulates the Activity of the ERK1/2-NF-κB Signaling Pathway in the Hippocampus and Prefrontal Cortex of Rats Exposed to Forced-Swimming Stress. Med Princ Pract 2016;25:539-47. [PMID: 27532271 DOI: 10.1159/000449165] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
42 Taylor P, Nutt D, Curran V, Fortson R, Henderson G. Ketamine—the real perspective. The Lancet 2016;387:1271-2. [DOI: 10.1016/s0140-6736(16)00681-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
43 Brandon NJ, McKay R. The cellular target of antidepressants. Nat Neurosci 2015;18:1537-8. [PMID: 26505563 DOI: 10.1038/nn.4144] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
44 Petschner P, Juhasz G, Tamasi V, Adori C, Tothfalusi L, Hökfelt T, Bagdy G. Chronic venlafaxine treatment fails to alter the levels of galanin system transcripts in normal rats. Neuropeptides 2016;57:65-70. [PMID: 26891823 DOI: 10.1016/j.npep.2016.01.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
45 Bhattacharya A, Derecki NC, Lovenberg TW, Drevets WC. Role of neuro-immunological factors in the pathophysiology of mood disorders. Psychopharmacology (Berl) 2016;233:1623-36. [PMID: 26803500 DOI: 10.1007/s00213-016-4214-0] [Cited by in Crossref: 90] [Cited by in F6Publishing: 80] [Article Influence: 15.0] [Reference Citation Analysis]
46 Harraz MM, Tyagi R, Cortés P, Snyder SH. Antidepressant action of ketamine via mTOR is mediated by inhibition of nitrergic Rheb degradation. Mol Psychiatry 2016;21:313-9. [PMID: 26782056 DOI: 10.1038/mp.2015.211] [Cited by in Crossref: 62] [Cited by in F6Publishing: 53] [Article Influence: 10.3] [Reference Citation Analysis]
47 Rantamäki T, Yalcin I. Antidepressant drug action — From rapid changes on network function to network rewiring. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2016;64:285-92. [DOI: 10.1016/j.pnpbp.2015.06.001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 5.5] [Reference Citation Analysis]
48 Allen A, Naughton M, Dowling J, Walsh A, Ismail F, Shorten G, Scott L, Mcloughlin D, Cryan J, Dinan T, Clarke G. Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT. Journal of Affective Disorders 2015;186:306-11. [DOI: 10.1016/j.jad.2015.06.033] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 7.3] [Reference Citation Analysis]
49 O'Brien FE, Moloney GM, Scott KA, O'Connor RM, Clarke G, Dinan TG, Griffin BT, Cryan JF. Chronic P-glycoprotein inhibition increases the brain concentration of escitalopram: potential implications for treating depression. Pharmacol Res Perspect 2015;3:e00190. [PMID: 27022464 DOI: 10.1002/prp2.190] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
50 O'Leary O, Nolan Y. Glycogen synthase kinase-3 as a therapeutic target for cognitive dysfunction in neuropsychiatric disorders. CNS Drugs 2015;29:1-15. [PMID: 25380674 DOI: 10.1007/s40263-014-0213-z] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 5.4] [Reference Citation Analysis]
51 Tang J, Xue W, Xia B, Ren L, Tao W, Chen C, Zhang H, Wu R, Wang Q, Wu H, Duan J, Chen G. Involvement of normalized NMDA receptor and mTOR-related signaling in rapid antidepressant effects of Yueju and ketamine on chronically stressed mice. Sci Rep 2015;5:13573. [PMID: 26315757 DOI: 10.1038/srep13573] [Cited by in Crossref: 76] [Cited by in F6Publishing: 86] [Article Influence: 10.9] [Reference Citation Analysis]
52 Gould RL, Coulson MC, Brown RG, Goldstein LH, Al-Chalabi A, Howard RJ. Psychotherapy and pharmacotherapy interventions to reduce distress or improve well-being in people with amyotrophic lateral sclerosis: A systematic review. Amyotroph Lateral Scler Frontotemporal Degener 2015;16:293-302. [PMID: 26174444 DOI: 10.3109/21678421.2015.1062515] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
53 Sheng ZF, Cui XY, Cui SY, Yu B, Zhang XQ, Li SJ, Cao Q, Huang YL, Xu YP, Song JZ, Ding H, Lin ZG, Yang G, Zhang YH. Involvement of adrenoceptors, dopamine receptors and AMPA receptors in antidepressant-like action of 7-O-ethylfangchinoline in mice. Acta Pharmacol Sin 2015;36:949-56. [PMID: 26238289 DOI: 10.1038/aps.2015.57] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
54 Milior G, Lecours C, Samson L, Bisht K, Poggini S, Pagani F, Deflorio C, Lauro C, Alboni S, Limatola C, Branchi I, Tremblay ME, Maggi L. Fractalkine receptor deficiency impairs microglial and neuronal responsiveness to chronic stress. Brain Behav Immun 2016;55:114-25. [PMID: 26231972 DOI: 10.1016/j.bbi.2015.07.024] [Cited by in Crossref: 111] [Cited by in F6Publishing: 112] [Article Influence: 15.9] [Reference Citation Analysis]
55 Réus GZ, Jansen K, Titus S, Carvalho AF, Gabbay V, Quevedo J. Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: Evidences from animal and human studies. J Psychiatr Res 2015;68:316-28. [PMID: 26028548 DOI: 10.1016/j.jpsychires.2015.05.007] [Cited by in Crossref: 109] [Cited by in F6Publishing: 98] [Article Influence: 15.6] [Reference Citation Analysis]
56 Hertz L, Rothman DL, Li B, Peng L. Chronic SSRI stimulation of astrocytic 5-HT2B receptors change multiple gene expressions/editings and metabolism of glutamate, glucose and glycogen: a potential paradigm shift. Front Behav Neurosci 2015;9:25. [PMID: 25750618 DOI: 10.3389/fnbeh.2015.00025] [Cited by in Crossref: 14] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
57 Duan D, Chen L, Yang X, Tu Y, Jiao S. Antidepressant-like effect of essential oil isolated from Toona ciliata Roem. var. yunnanensis. J Nat Med 2015;69:191-7. [DOI: 10.1007/s11418-014-0878-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
58 Levone BR, Cryan JF, O'Leary OF. Role of adult hippocampal neurogenesis in stress resilience. Neurobiol Stress 2015;1:147-55. [PMID: 27589664 DOI: 10.1016/j.ynstr.2014.11.003] [Cited by in Crossref: 92] [Cited by in F6Publishing: 98] [Article Influence: 11.5] [Reference Citation Analysis]